Genetic Engineering News
IntegenX secured $40 Million in Series C funding. The company plans on using the money to accelerate development of its product pipeline and to commercialize the RapidHIT™ 200 Human Identification System.
The power to see it all in a single assay!
Cycling time of less than 50 minutes saves hours
Powerplex Fusion is NDIS Approved!